Do new devices add to the results of PTCA in acute myocardial infarction?

J. Moses, I. Moussa

Research output: Contribution to journalArticlepeer-review


Several randomized trials have established that timely mechanical reperfusion with the use of balloon angioplasty is superior to thrombolytic therapy in patients with acute myocardial infarction. Furthermore, recent data from prospective randomized trials suggest that primary stent implantation may further improve the results of balloon angioplasty by reducing the need for repeat interventions at follow-up. The role of IIb- IIIa platelet receptor antagonists as adjunctive therapy to catheter-based coronary interventions in acute myocardial infarction is promising, but the incremental benefit that these agents add to stent implantation awaits the results of dedicated randomized trials. Mechanical thrombolysis or thrombectomy devices may have a role in a minority of patients with large thrombus burden.

Original languageEnglish (US)
Pages (from-to)S158-S163
JournalAmerican Heart Journal
Issue number2 II
StatePublished - 1999
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Do new devices add to the results of PTCA in acute myocardial infarction?'. Together they form a unique fingerprint.

Cite this